期刊文献+

Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft 被引量:5

Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft
下载PDF
导出
摘要 BACKGROUND: Although the use of non-heart beating donors (NHBDs) could bridge the widening gap between organ demand and supply, its application to liver transplantation is limited due to the high incidence of primary graft loss. Prevention of liver injury in NHBDs will benefit the results of transplantation. This study was conducted to evaluate the protective effects of L-arginine on liver grafts from NHBDs. METHODS: One hundred and four Wistar rats were randomly divided into 7 groups: normal control (n=8) controls 1, 2 and 3 (C-1, C-2, C-3, n=16), and experimental 1, 2 and 3 (E-1, E-2, E-3, n=16). For groups C-1 and E-1, C-2 and E-2, and C-3 and E-3, the warm ischemia time was 0, 30, and 45 minutes, respectively. Liver grafts were flushed with and preserved in 4 degrees C Euro-collins solution containing 1 mmol/L L-arginine for 1 hour in each experimental group. Recipients of each experimental group were injected with L-arginine (10 mg/kg body weight) by tail vein 10 minutes before portal vein reperfusion. Donors and recipients of each experimental control group were treated with normal saline. Then transplantation was performed. At 1, 3, and 24 hours after portal vein reperfusion, blood samples were obtained to determine the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), nitric oxide (NO) and plasma endothelin (ET). At 3 hours after portal vein reperfusion, grafts samples were fixed in 2.5% glutaraldehyde for electron microscopic observation. RESULTS: At I hour after portal vein reperfusion, the levels of NO in groups E-1, E-2, E-3 and C-1, C-2, C-3 were lower, while the levels of plasma ET, serum ALT and AST were higher than those in the normal control group (P<0.05). At 1, 3, and 24 hours, the levels of NO in groups E-1, E-2, E-3 were higher, while the levels of plasma ET, serum ALT and AST were lower than those in the corresponding control groups (C-1, C-2, C-3) (P<0.05). The levels of NO in groups C-2 and C-3 were lower than in group C-1 (P<0.05), and the level of NO in group C-3 was lower than in group C-2 (P<0.05). At 1, 3 and 24 hours, the levels of plasma ET, serum ALT, and AST in groups E-1, E-2, E-3 were lower than those in the corresponding control groups (C-1, C-2, C-3) (P<0.05). The levels of plasma ET, serum ALT, and AST were lower in group C-3 than in groups C-1 and C-2 (P<0.05). Pathological changes in groups E-1, E-2, E-3 were milder than those in the corresponding experimental control groups (C-1, C-2, C-3). CONCLUSIONS: The imbalance between NO and ET plays an important role in the development of ischemia-reperfusion injury of liver grafts from NHBDs. L-arginine can attenuate injury in liver grafts from NHBDs by improving the balance between NO and ET. BACKGROUND: Although the use of non-heart beating donors (NHBDs) could bridge the widening gap between organ demand and supply, its application to liver transplantation is limited due to the high incidence of primary graft loss. Prevention of liver injury in NHBDs will benefit the results of transplantation. This study was conducted to evaluate the protective effects of L-arginine on liver grafts from NHBDs. METHODS: One hundred and four Wistar rats were randomly divided into 7 groups: normal control (n=8) controls 1, 2 and 3 (C-1, C-2, C-3, n=16), and experimental 1, 2 and 3 (E-1, E-2, E-3, n=16). For groups C-1 and E-1, C-2 and E-2, and C-3 and E-3, the warm ischemia time was 0, 30, and 45 minutes, respectively. Liver grafts were flushed with and preserved in 4 degrees C Euro-collins solution containing 1 mmol/L L-arginine for 1 hour in each experimental group. Recipients of each experimental group were injected with L-arginine (10 mg/kg body weight) by tail vein 10 minutes before portal vein reperfusion. Donors and recipients of each experimental control group were treated with normal saline. Then transplantation was performed. At 1, 3, and 24 hours after portal vein reperfusion, blood samples were obtained to determine the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), nitric oxide (NO) and plasma endothelin (ET). At 3 hours after portal vein reperfusion, grafts samples were fixed in 2.5% glutaraldehyde for electron microscopic observation. RESULTS: At I hour after portal vein reperfusion, the levels of NO in groups E-1, E-2, E-3 and C-1, C-2, C-3 were lower, while the levels of plasma ET, serum ALT and AST were higher than those in the normal control group (P<0.05). At 1, 3, and 24 hours, the levels of NO in groups E-1, E-2, E-3 were higher, while the levels of plasma ET, serum ALT and AST were lower than those in the corresponding control groups (C-1, C-2, C-3) (P<0.05). The levels of NO in groups C-2 and C-3 were lower than in group C-1 (P<0.05), and the level of NO in group C-3 was lower than in group C-2 (P<0.05). At 1, 3 and 24 hours, the levels of plasma ET, serum ALT, and AST in groups E-1, E-2, E-3 were lower than those in the corresponding control groups (C-1, C-2, C-3) (P<0.05). The levels of plasma ET, serum ALT, and AST were lower in group C-3 than in groups C-1 and C-2 (P<0.05). Pathological changes in groups E-1, E-2, E-3 were milder than those in the corresponding experimental control groups (C-1, C-2, C-3). CONCLUSIONS: The imbalance between NO and ET plays an important role in the development of ischemia-reperfusion injury of liver grafts from NHBDs. L-arginine can attenuate injury in liver grafts from NHBDs by improving the balance between NO and ET.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2008年第5期481-484,共4页 国际肝胆胰疾病杂志(英文版)
基金 a grant from the Science & Technology Development Foundation of Guangdong Health Bureau(No.2006345).
关键词 liver transplantation non-heart beating donor L-ARGININE nitric oxide ischemia-reperfusion injury liver transplantation non-heart beating donor L-arginine nitric oxide ischemia-reperfusion injury
  • 相关文献

参考文献19

  • 1Guang-JinYuan,Jin-ChunMa,Zuo-JiongGong,Xiao-MeiSun,Shi-HuaZheng,XiLi.Modulation of liver oxidant-antioxidant system by ischemic preconditioning during ischemia/reperfusion injury in rats[J].World Journal of Gastroenterology,2005,11(12):1825-1828. 被引量:20
  • 2Shui-Jun Zhang, Ji-Hua Shi, Zhe Tang, Yang Wu and Shi Chen Zhengzhou, China Department of Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China ,Institute of Organ Transplantation, Tongji Medical College , Huazhong University of Science and Technology, Wuhan 430030 , China.Protective effects of glycine pretreatment on brain-death donor liver[J].Hepatobiliary & Pancreatic Diseases International,2005,4(1):37-40. 被引量:5
  • 3Zheng SS,,Shi QF,Liang TB,Wu J,Wang WL,Shen Y,et al.Orthotopic liver transplantation for patients with Klatskintumor. Journal of Hepatobiliary Pancreat Disease . 2005
  • 4Bessems M,,Doorschodt BM,van Marle J,Vreeling H,Meijer AJ,van Gulik TM.Improved machine perfusionpreservation of the non-heart-beating donor rat liver usingPolysol:a new machine perfusion preservation solution. Liver Transplantation . 2005
  • 5Kume M,Banafsche R,Yamamoto Y,Yamaoka Y,NobilingR,Gebhard MM,et al.Dynamic changes of post-ischemichepatic microcirculation improved by a pre-treatment ofphosphodiesterase-3 inhibitor,milrinone. JSurgRes . 2006
  • 6Terluk M,Cunha Da Silva E,Antunes T,Assreuy J.Thepresence of the endothelial layer reduces nitric oxide-induced hyporesponsiveness to phenylephrine in rat aorta. Endothelium . 2004
  • 7Gonon AT,Erbas D,Broijersén A,Valen G,Pernow J.Nitricoxide mediates protective effect of endothelin receptorantagonism during myocardial ischemia and reperfusion. American Journal of Physiology Heart and Circulatory Physiology . 2004
  • 8Koeppel TA,Mihaljevic N,Kraenzlin B,Loehr M,Jesenofsky R,Post S,et al.Enhanced iNOS gene expressionin the steatotic rat liver after normothermic ischemia. European Surgical Research . 2007
  • 9Fernández N,Martínez MA,Climent B,García-VillalónAL,Monge L,Sanz E,et al.In vivo coronary effects ofendothelin-1 after ischemia-reperfusion.Role of nitricoxide and prostanoids. European Journal of Pharmacology . 2003
  • 10Symons JD,Hayashi Y,Ensunsa JL.Improved coronaryvascular function evoked by high-intensity treadmilltraining is maintained in arteries exposed to ischemia andreperfusion. Journal of Applied Physiology . 2003

二级参考文献3

共引文献31

同被引文献17

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部